Inventor
LAN JIONG
CN36 patents
⚠️ This page may combine multiple inventors who share the name “LAN JIONG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD
12 patentsUS10100047B2Oct 16, 2018
Piperidine derivatives as orexin receptor antagonist
SHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD5 citations72
US10815197B2Oct 27, 2020
N-sulfonyl benzamides as voltage-gated sodium channel inhibitors
SHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD2 citations71
US10435400B2Oct 8, 2019
2,4-disubstituted phenylene-1,5-diamine derivatives and applications thereof, and pharmaceutical compositions and pharmaceutically acceptable compositions prepared therefrom
SHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD3 citations71
US10577346B2Mar 3, 2020
Benzobicycloalkane derivatives, their preparation and pharmaceutical use thereof
SHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD1 citations60
US11174254B2Nov 16, 2021
Aniline-substituted 1,2-dihydropyrrol[3,4-C]pyridin/pyrimidin-3-one derivative and use thereof
SHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD0 citations59
US11155546B2Oct 26, 2021
4,6,7-trisubstituted 1,2-dihydropyrrolo[3,4-c]pyridin/pyrimidin-3-one derivatives and uses thereof
SHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD1 citations59
US10561646B2Feb 18, 2020
EGFR inhibitor and pharmaceutically acceptable salt and polymorph thereof, and use thereof
SHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD1 citations55
US9879008B2Jan 30, 2018
2,3,4,6-tetra-substituted benzene-1,5-diamine derivatives, preparation method therefor and medicinal use thereof
SHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD1 citations48
US11104664B2Aug 31, 2021
4,5,6-trisubstituted indazole derivatives, and preparation method and pharmaceutical use thereof
SHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD0 citations47
US9890168B2Feb 13, 2018
2,4-disubstituted 7H-pyrrolo[2,3-d]pyrimidine derivative, preparation method and medicinal use thereof
SHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD0 citations38
US10085983B2Oct 2, 2018
Azabicyclo derivatives, process for preparation thereof and medical use thereof
SHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD0 citations36
US10793549B2Oct 6, 2020
Sulfuryl-substituted benzoheterocyclic derivative, preparation method and medical use thereof
SHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD0 citations34
NOVARTIS AG
5 patentsUS7569571B2Aug 4, 2009
Substituted pyrazolo [3,4-d]pyrimidines as cytokine modulators
NOVARTIS AG104 citations97
US7754726B2Jul 13, 2010
Benzamide derivatives as p-38 kinase inhibitors
NOVARTIS AG20 citations91
US7863314B2Jan 4, 2011
5-membered heterocycle-based p38 kinase inhibitors
NOVARTIS AG4 citations72
US8580838B2Nov 12, 2013
5-membered heterocycle-based p38 kinase inhibitors
NOVARTIS AG2 citations61
US7700622B2Apr 20, 2010
p-38 kinase inhibitors
NOVARTIS AG0 citations51
BURGER MATTHEW
4 patentsUS8168794B2May 1, 2012
Pim kinase inhibitors and methods of their use
BURGER MATTHEW36 citations90
US8822497B2Sep 2, 2014
PIM kinase inhibitors and methods of their use
BURGER MATTHEW10 citations80
US8829193B2Sep 9, 2014
PIM kinase inhibitors and methods of their use
BURGER MATTHEW5 citations71
US8759338B2Jun 24, 2014
Heterocyclic kinase inhibitors
BURGER MATTHEW0 citations51
BURGER MATTHEW T
3 patentsJIANGSU HENGRUI MEDICINE CO
2 patentsFRYSZMAN OLGA M
2 patentsGENFLEET THERAPEUTICS SHANGHAI INC
2 patentsUS12054497B2Aug 6, 2024
Substituted heterocyclic fused cyclic compound, preparation method therefor and pharmaceutical use thereof
GENFLEET THERAPEUTICS SHANGHAI INC3 citations66
US12384774B2Aug 12, 2025
Polymorph of CDK9 inhibitor and preparation method for polymorph and use thereof
GENFLEET THERAPEUTICS SHANGHAI INC0 citations58